Events

EU Standardisation Priorities - Quantum Technologies
OCT
Thu
13
11:30 - 13:00

This was 2 years ago

Location

Online

Programmes
Digital, Industry & Space

StandICT.eu, which unites the ICT standard experts, organises regularly an inspirational webinar - called walk & talk. The next ediation will be on quantum technologies. You'll get as main takeaways: Overview of Standards patterns in the field, Ongoing initiatives & Future Directions.

Quantum Technologies will make it possible to do things that might seem unthinkable today. With quantum, it will be possible to perform sophisticated computational tasks, like modelling biomolecular and chemical reactions, that the most powerful supercomputers cannot currently manage. Quantum will allow us to send sensitive information safely to anywhere, or even diagnose diseases quicker by looking inside cells.

Europe has a long-lasting tradition of excellence in quantum research. This legacy is brought forward with the Quantum Technologies Flagship, a large-scale, long-term research initiative funded by the EU that brings together research institutions, industry and public funders, consolidating and expanding European scientific leadership and excellence in this field.

This webinar will deal with the “State of the Art” in Quantum Technologies Standardisation, discuss European Policy and Strategies for development of adoption of Quantum Technologies within the Digital Single Market, presenting expert contributions from European and International Standards Development Organisations (SDOs).

Agenda 

  • Ray Walshe - StandICT.eu 2023 EUOS Director
  • Oscar Diez - Head of Sector Quantum Computing at European Commission
  • Richard Pitwon - Chair IEC TC 86/SC 86B & StandICT.eu 2023 Fellow 
  • Nicolas Spethmann - Co-chairs of Cen-Cenelec FGQT
  • Nooshin Amirifar - Project Manager and Secretariat member of Cen-Cenelec FGQT
  • Jonathan J. Attia - President at Feynam Foundation and Chair of IEEE 2995 WG

 

More information & registration on the event website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.